Rule Requiring Drug Prices in TV Ads Blocked by Judge
A Trump administration rule to force pharmaceutical companies to disclose the list prices of their drugs in television ads was blocked by a federal judge.
Regulatory Issues
FDA: New Plan for Regulations, Oversight of Dietary Supplement Industry
The FDA has announced a new plan to significantly modernize the regulation and oversight of dietary supplements.
Name-Brand Medications Driving Spike in U.S. Drug Spending
Rising drug spending in the United States is being fueled by expensive name-brand prescription medicines.
Overcoming the Barriers to Including Pregnant Women in Clinical Trials
Pregnant women are considered a “vulnerable” population in the eyes of clinical researchers.
CDC: 8.8% of Individuals in the United States Uninsured in First Half of 2018
In the first six months of 2018, 8.8 percent of U.S. individuals of all ages were uninsured, which was not significantly different from 2017.
ACA Coverage Substantial, but Did Not Impact Labor Markets
Millions of workers gained insurance coverage under the Affordable Care Act (ACA) without adverse effects on labor markets.
Childrens’ Pain Reliever Recalled Due to Potentially Higher Potency Level
Ingesting nonsteroidal anti-inflammatory drugs (NSAID) at a higher potency level may cause nausea, vomiting, epigastric pain, diarrhea, tinnitus, headache, and even gastrointestinal bleeding; pediatric patients are also at greater risk of developing NSAID-associated renal injury.
Patient, Consumer Groups Push for Injunction Against Short-Term Insurance Rule
The American Heart Association and others are urging the court to reconsider changes to short-term limited-duration insurance plans.
Examining the Issues Leading to Market Withdrawal of the Zecuity Patch
According to an article published in Headache, the US Food and Drug Administration (FDA) was aware of safety issues associated with the Zecuity transdermal patch for migraine prior to its approval.
FDA Launches MyStudies Mobile App in Effort to Increase Access to Real World Patient Data
The FDA has launched the MyStudies App, a mobile application aimed at supporting the collection of “real world” data and evidence for medical use.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Regulatory Issues
Loading... 
Loading...